GSK has reported much-needed progress with two of its cancer therapies, with a phase 3 trial win for immunotherapy Jemperli in endometrial cancer and the start of a review in the EU for myelofibrosis ...
Our youth-led programmes place physical and mental wellbeing at their core, whilst also creating healthy futures and healthy communities. Register and be the first to hear about our events and news.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback